Impilo (Enterprise Systems (Healthcare))
$11.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Impilo (Enterprise Systems (Healthcare)) is currently valued at $42.0M as of July 12, 2024. The company has raised a total of $18.4M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.29x, Impilo (Enterprise Systems (Healthcare)) has achieved a valuation that is 2.29 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
Impilo (Enterprise Systems (Healthcare))'s valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Impilo (Enterprise Systems (Healthcare)) Worth in 2025?
As of 2025, Impilo (Enterprise Systems (Healthcare)) is valued at $42.0M, based on the company's Early Stage VC funding round in July 12, 2024. This valuation positions Impilo (Enterprise Systems (Healthcare)) as one of the leading private companies in the sector.
Impilo (Enterprise Systems (Healthcare)) Valuation History
Impilo (Enterprise Systems (Healthcare))'s funding history demonstrates steady growth and investor confidence.
How Impilo (Enterprise Systems (Healthcare)) Valuation is Determined
Private company valuations like Impilo (Enterprise Systems (Healthcare))'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Impilo (Enterprise Systems (Healthcare)) Valuation FAQs
Is Impilo (Enterprise Systems (Healthcare)) profitable?
Impilo (Enterprise Systems (Healthcare)) has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Impilo (Enterprise Systems (Healthcare))'s valuation compare to competitors?
Impilo (Enterprise Systems (Healthcare)) is valued at $42.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Impilo (Enterprise Systems (Healthcare)) IPO?
Impilo (Enterprise Systems (Healthcare)) has not announced plans for an initial public offering. Until an IPO, investors can access Impilo (Enterprise Systems (Healthcare)) shares through secondary market platforms.